Citi says weakness in shares of this pharma stock is "overdone"

September 9, 2026 12:00 PM

Investing.com - Shares of this buyer of biopharmaceutical royalty rights fell by more than 5% on Tuesday, after an experimental ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found